Analysis of Pharmaceutical Care in Clinical Treatment of a Child with Severe Mycoplasma Pneumoniae Pneumonia
Objective:To analyze the treatment regimen and pharmaceutical care process of severe Mycoplasma pneumoniae pneumonia(SMPP)in children,and provide a reference for drug treatment of SMPP in children.Methods and Results:The child was admitted to the hospital for treatment due to"fever for 7 days and cough for 5 days".In combination with the child's clinical manifestations and examination results,pneumonia was considered;then azithromycin and ceftazidime were administered empirically,supplemented with relieving cough and reducing sputum;but after a full course of azithromycin,the child's symptoms were not alleviated obviously,and the etiological examination reported positive Mycoplasma pneumoniae,which was considered to be resistant to azithromycin;the clinical pharmacist recommended doxycycline after considering the child's age and relevant literature results,and the doctor and family members adopted the recommendation.The child improved and was discharged after 6 days,and the follow-up after 6 weeks showed a good prognosis.Conclusion:Clinical pharmacists participate in the clinical treatment of patients throughout the process and implement pharmaceutical care,which effectively promotes the clinically rational medication and ensures the safety of medication for children.
severe Mycoplasma pneumoniae pneumoniachildrenpharmaceutical careclinical pharmacist
NETL
NSTL
万方数据
